Discover 1,359 paid clinical trials in Athens, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,359
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
for
Bladder Cancer
Location: Atlanta GA, Knoxville TN, Nashville TN, Raleigh NC,
Location: Atlanta GA, Birmingham AL, Charleston SC,
Sponsor: Arga Medtech SA
Sex: All
Age: 18 - 70+
Code: NCT06784466
Recruiting
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
for
Non-muscle Invasive Bladder Cancer
Location: Atlanta GA, Birmingham AL, Nashville TN,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07206225
Phase1, Recruiting
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
for
Relapsed or Refractory Multiple Myeloma
Location: Atlanta GA, Charlotte NC, Birmingham AL, Nashville TN,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 18+
Code: NCT07116616
Phase1, Phase2, Recruiting
Ivosidenib as Post-HSCT Maintenance for AML
for
IDH1 Mutation, Acute Myeloid Leukemia (AML),
Location: Atlanta GA, Columbus OH, Milwaukee WI, Kansas City KS,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18 - 70+
Code: NCT06707493
Phase2, Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
for
Coronary Arterial Disease (CAD),
Location: Atlanta GA, Marietta GA, Columbia SC, Charlotte NC,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT06959524
Recruiting
PKU Protein Requirements
for
PKU
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18+
Code: NCT07194993
Recruiting
A Phase 1 Open-Label Study of the Safety of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) in Young Adult (1A) and Pediatric (1B) Patients With Dilated Cardiomyopathy (DCM)
for
Dilated Cardiomyopathy
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 4 - 40
Code: NCT06464588
Phase1, Recruiting
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
for
Acute Myeloid Leukemia
Location: Atlanta GA, Cincinnati OH, Orlando FL, Columbus OH,
Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland